Abstract
Background
Atrial fibrillation is the most common arrhythmia in clinical practice and is a major contributor to mortality. Recently, several studies have reported different results for treatments aimed at reducing the risk of postoperative AF.
Aims
The aim of this study was to evaluate the efficacy of beta-blockers (BBs) in preventing post-coronary artery bypass grafting (CABG) AF and to compare the efficacies of different BB treatments using a network meta-analytical approach.
Methods
The PubMed, EMBASE and Cochrane Library databases were searched (Jan 1995 to May 2014) to identify randomized controlled trials. Two independent investigators separately extracted the data using a seven-point scoring system to assess randomization, allocation concealment, blinding, withdrawals and dropouts. A direct meta-analysis of these randomized controlled trials was conducted. Then, six trials comparing different BB treatments for the prevention of postoperative AF were added to perform a Bayesian network meta-analysis with mixed treatment comparisons.
Results
Treatment with BBs was associated with a significant reduction in the postoperative incidence of AF compared with placebo/control [22.37 % compared with 34.45 %, relative risk (RR) = 0.53, 95 % confidence interval (CI): 0.37–0.75, p < 0.00001].
Conclusions
The network meta-analysis revealed no significant differences among eight types of BB treatments but did provide a ranking. BB treatments could significantly reduce the occurrence of post-CABG AF. Insufficient evidence was available to show that one BB treatment was more effective than the others were. According to our network meta-analysis, bisoprolol and landiolol+bisoprolol are better alternatives compared with the other treatments.
Similar content being viewed by others
References
Cox JL (1993) A perspective of postoperative atrial fibrillation in cardiac operations. Ann Thorac Surg 56(3):405–409
Mariscalco G, Engstrom KG (2009) Postoperative atrial fibrillation is associated with late mortality after coronary surgery, but not after valvular surgery. Ann Thorac Surg 88(6):1871–1876. doi:10.1016/j.athoracsur.2009.07.074
Kaw R, Hernandez AV, Masood I, Gillinov AM, Saliba W, Blackstone EH (2011) Short- and long-term mortality associated with new-onset atrial fibrillation after coronary artery bypass grafting: a systematic review and meta-analysis. J Thorac Cardiovasc Surg 141(5):1305–1312. doi:10.1016/j.jtcvs.2010.10.040
Babin-Ebell J, Keith PR, Elert O (1996) Efficacy and safety of low-dose propranolol versus diltiazem in the prophylaxis of supraventricular tachyarrhythmia after coronary artery bypass grafting. Eur J Cardiothorac Surg: Off J Eur Assoc Cardiothorac Surg 10(6):412–416
Wenke K, Parsa MH, Imhof M, Kemkes BM (1999) Efficacy of metoprolol in prevention of supraventricular arrhythmias after coronary artery bypass grafting. Z Kardiol 88(9):647–652
Lucio Ede A, Flores A, Blacher C, Leaes PE, Lucchese FA, Ribeiro JP (2004) Effectiveness of metoprolol in preventing atrial fibrillation and flutter in the postoperative period of coronary artery bypass graft surgery. Arq Bras Cardiol 82((1):42–46):37–41
Connolly SJ, Cybulsky I, Lamy A, Roberts RS, O’Brien B, Carroll S, Crystal E, Thorpe KE, Gent M, Beta-Blocker Length of Stay s (2003) Double-blind, placebo-controlled, randomized trial of prophylactic metoprolol for reduction of hospital length of stay after heart surgery: the beta-blocker length of stay (BLOS) study. Am Heart J 145(2):226–232. doi:10.1067/mhj.2003.147
Ogawa S, Okawa Y, Goto Y, Aoki M, Baba H (2013) Perioperative use of a beta blocker in coronary artery bypass grafting. Asian Cardiovasc Thorac Ann 21(3):265–269. doi:10.1177/0218492312451166
Sakaguchi M, Sasaki Y, Hirai H, Hosono M, Nakahira A, Seo H, Suehiro S (2012) Efficacy of landiolol hydrochloride for prevention of atrial fibrillation after heart valve surgery. Int Heart J 53(6):359–363
Paull DL, Tidwell SL, Guyton SW, Harvey E, Woolf RA, Holmes JR, Anderson RP (1997) Beta blockade to prevent atrial dysrhythmias following coronary bypass surgery. Am J Surg 173(5):419–421. doi:10.1016/S0002-9610(97)00077-9
Yazicioglu L, Eryilmaz S, Sirlak M, Inan MB, Aral A, Tasoz R, Akalin H (2002) The effect of preoperative digitalis and atenolol combination on postoperative atrial fibrillation incidence. Eur J Cardiothorac Surg: Off J Eur Assoc Cardiothorac Surg 22(3):397–401
Imren Y, Benson AA, Zor H, Tasoglu I, Ereren E, Sinci V, Gokgoz L, Halit V (2007) Preoperative beta-blocker use reduces atrial fibrillation in off-pump coronary bypass surgery. ANZ J Surg 77(6):429–432. doi:10.1111/j.1445-2197.2007.04088.x
Sezai A, Nakai T, Hata M, Yoshitake I, Shiono M, Kunimoto S, Hirayama A (2012) Feasibility of landiolol and bisoprolol for prevention of atrial fibrillation after coronary artery bypass grafting: a pilot study. J Thorac Cardiovasc Surg 144(5):1241–1248. doi:10.1016/j.jtcvs.2012.06.042
Skiba MA, Pick AW, Chaudhuri K, Bailey M, Krum H, Kwa LJ, Rosenfeldt FL (2013) Prophylaxis against atrial fibrillation after cardiac surgery: beneficial effect of perioperative metoprolol. Heart Lung Circ 22(8):627–633. doi:10.1016/j.hlc.2012.12.017
Bert AA, Reinert SE, Singh AK (2001) A beta-blocker, not magnesium, is effective prophylaxis for atrial tachyarrhythmias after coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth 15(2):204–209. doi:10.1053/jcan.2001.21959
Khan MF, Wendel CS, Movahed MR (2013) Prevention of post-coronary artery bypass grafting (CABG) atrial fibrillation: efficacy of prophylactic beta-blockers in the modern era: a meta-analysis of latest randomized controlled trials. Ann Noninvasive Electrocardiol 18(1):58–68. doi:10.1111/anec.12004
Trelle S, Reichenbach S, Wandel S, Hildebrand P, Tschannen B, Villiger PM, Egger M, Juni P (2011) Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis. BMJ 342:c7086. doi:10.1136/bmj.c7086
Tang DH, Malone DC (2012) A network meta-analysis on the efficacy of serotonin type 3 receptor antagonists used in adults during the first 24 hours for postoperative nausea and vomiting prophylaxis. Clin Ther 34(2):282–294. doi:10.1016/j.clinthera.2012.01.007
Sezai A, Minami K, Nakai T, Hata M, Yoshitake I, Wakui S, Shiono M, Hirayama A (2011) Landiolol hydrochloride for prevention of atrial fibrillation after coronary artery bypass grafting: new evidence from the PASCAL trial. J Thorac Cardiovasc Surg 141(6):1478–1487. doi:10.1016/j.jtcvs.2010.10.045
Haghjoo M, Saravi M, Hashemi MJ, Hosseini S, Givtaj N, Ghafarinejad MH, Khamoushi AJ, Emkanjoo Z, Fazelifar AF, Alizadeh A, Sadr-Ameli MA (2007) Optimal beta-blocker for prevention of atrial fibrillation after on-pump coronary artery bypass graft surgery: carvedilol versus metoprolol. Heart Rhythm: Off J Heart Rhythm Soc 4(9):1170–1174. doi:10.1016/j.hrthm.2007.04.022
Acikel S, Bozbas H, Gultekin B, Aydinalp A, Saritas B, Bal U, Yildirir A, Muderrisoglu H, Sezgin A, Ozin B (2008) Comparison of the efficacy of metoprolol and carvedilol for preventing atrial fibrillation after coronary bypass surgery. Int J Cardiol 126(1):108–113. doi:10.1016/j.ijcard.2007.03.123
Iliuta L, Christodorescu R, Filpescu D, Moldovan H, Radulescu B, Vasile R (2009) Prevention of perioperative atrial fibrillation with beta blockers in coronary surgery: betaxolol versus metoprolol. Interact Cardiovasc Thorac Surg 9(1):89–93. doi:10.1510/icvts.2009.202465
Marazzi G, Iellamo F, Volterrani M, Caminiti G, Madonna M, Arisi G, Massaro R, Righi D, Rosano GM (2011) Comparison of effectiveness of carvedilol versus bisoprolol for prevention of postdischarge atrial fibrillation after coronary artery bypass grafting in patients with heart failure. Am J Cardiol 107(2):215–219. doi:10.1016/j.amjcard.2010.08.062
Ozaydin M, Icli A, Yucel H, Akcay S, Peker O, Erdogan D, Varol E, Dogan A, Okutan H (2013) Metoprolol vs carvedilol or carvedilol plus N-acetyl cysteine on post-operative atrial fibrillation: a randomized, double-blind, placebo-controlled study. Eur Heart J 34(8):597–604. doi:10.1093/eurheartj/ehs423
Gross JL, Kramer CK, Leitao CB, Hawkins N, Viana LV, Schaan BD, Pinto LC, Rodrigues TC, Azevedo MJ, Diabetes, Endocrinology Meta-analysis G (2011) Effect of antihyperglycemic agents added to metformin and a sulfonylurea on glycemic control and weight gain in type 2 diabetes: a network meta-analysis. Ann Intern Med 154(10):672–679. doi:10.7326/0003-4819-154-10-201105170-00007
Leggett CL, Gorospe EC, Calvin AD, Harmsen WS, Zinsmeister AR, Caples S, Somers VK, Dunagan K, Lutzke L, Wang KK, Iyer PG (2014) Obstructive sleep apnea is a risk factor for Barrett’s esophagus. Clin Gastroenterol Hepatol: Off Clin Pract J Am Gastroenterol Assoc 12(4):583.e1–588.e1. doi:10.1016/j.cgh.2013.08.043
Acknowledgments
Sponsored by the National Natural Science Foundation of China (Grant No. 81000117, 81370266), and Natural Science Foundation of Shanghai (Grant No. 15ZR1413600).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
None declared.
Ethical approval
This article is a systematic review. There is no need to obtain ethical approval.
Additional information
T. Ji, C. Feng, and L. Sun contributed equally to this work.
J. Zhu and X. Zhao also contributed equally to this work.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Ji, T., Feng, C., Sun, L. et al. Are beta-blockers effective for preventing post-coronary artery bypass grafting atrial fibrillation? Direct and network meta-analyses. Ir J Med Sci 185, 503–511 (2016). https://doi.org/10.1007/s11845-016-1447-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11845-016-1447-1